Fred Alger Management »

BioMarin Pharmaceutical shares owned by Fred Alger Management

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Fred Alger Management from 13F filings

Historical chart of Fred Alger Management investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Fred Alger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Fred Alger Management

Quarter filed Position value Share count Share price at filing
2013-03-31 $17M 272k 62.26

More positions owned by Fred Alger Management

Microsoft Corp Common (MSFT)
Nvidia Corp. Common (NVDA)
Amazon Common (AMZN)
Apple Common (AAPL)
Meta Platforms Inc Class A Common (META)
Broadcom Common (AVGO)
Natera Common (NTRA)
Applovin Corp Class A Common (APP)
Gfl Environmental Common (GFL)
Alphabet Inc Cl C Common (GOOG)
Taiwan Semiconductor Common (TSM)
Vertiv Holdings Common (VRT)
Visa Inc Class A Shares Common (V)
Netflix Common (NFLX)
S&p Global Common (SPGI)

View all positions for Fred Alger Management

Top funds holding BioMarin Pharmaceutical

BlackRock
BlackRock
Vanguard Group
PRIMECAP Management Company
Dodge & Cox
Capital Research Global Investors
Viking Global Investors
State Street Corporation
Elliott Investment Management
Geode Capital Management
Jpmorgan Chase & Co
Bank of New York Mellon
Citadel Advisors
Deutsche Bank Aktiengesellschaft
Northern Trust

View all funds holding BioMarin Pharmaceutical